Ubiquitin expression in muscle from horses with polysaccharide storage myopathy.

This research paper studies the occurrence of ubiquitin expression in muscles of horses diagnosed with equine polysaccharide storage myopathy (EPSSM), a muscle disease. The study found that ubiquitin was generally present in all but one EPSSM horse and absent in non-EPSSM horses, suggesting that ubiquitin immunostaining may be useful for confirming an EPSSM diagnosis but is no more effective than the previous method using periodic acid-Schiff (PAS) staining.

Sample Collection and Treatment

• The researchers collected muscle biopsy specimens from a group of 28 horses across several breeds. These samples were formally fixed in formalin and embedded in paraffin.
• The specimens were then treated using a PAS stain, a common staining procedure used to detect polysaccharides like glycogen, and were also immunostained to identify ubiquitin expression.

Determination of Findings

• Of the 28 horse samples, 22 were diagnosed with EPSSM based on the results of the PAS-stained sections. These horses were aged between 2 and 23 years.
• The other six horses, which ranged from 0.5 to 15 years old, demonstrated a normal PAS staining pattern with no significant lesions, therefore they were deemed not affected by EPSSM.
• Ubiquitin expression was identified in all the EPSSM-affected horses barring one. On the contrary, it was not present in the non-EPSSM horses.

Ubiquitin Expression and Diagnosis of EPSSM

• The degree of ubiquitin expression was higher than the degree of PAS-positive, resistant material. Importantly, ubiquitin was detected in both amylase-sensitive glycogen aggregates and in amylase-resistant material.
• This suggests that glycogen aggregates develop and are marked by ubiquitin prior to the formation of amylase-resistant inclusions.
• The study concluded that ubiquitin immunostaining might be useful to confirm the diagnosis of EPSSM in horses, especially those with only amylase-sensitive glycogen and those with early amylase-resistant inclusions.
• However, the sensitivity of ubiquitin immunostaining for the diagnosis of EPSSM was not deemed higher than the sensitivity of PAS staining. This suggests that both diagnostic methods could be utilized with similar degrees of accuracy.